ID   LPCT4_HUMAN             Reviewed;         524 AA.
AC   Q643R3; A8K2K8; O43412; Q7Z4P4; Q8IUL7; Q8TB38;
DT   25-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   25-OCT-2004, sequence version 1.
DT   10-MAY-2017, entry version 128.
DE   RecName: Full=Lysophospholipid acyltransferase LPCAT4;
DE   AltName: Full=1-acylglycerol-3-phosphate O-acyltransferase 7;
DE            Short=1-AGP acyltransferase 7;
DE            Short=1-AGPAT 7;
DE   AltName: Full=1-acylglycerophosphocholine O-acyltransferase;
DE            EC=2.3.1.23;
DE   AltName: Full=1-acylglycerophosphoserine O-acyltransferase;
DE            EC=2.3.1.n6;
DE   AltName: Full=1-alkenylglycerophosphoethanolamine O-acyltransferase;
DE            EC=2.3.1.121;
DE   AltName: Full=1-alkylglycerophosphocholine O-acetyltransferase;
DE            EC=2.3.1.67;
DE   AltName: Full=Acyltransferase-like 3;
DE   AltName: Full=Lysophosphatidylcholine acyltransferase 4;
DE   AltName: Full=Lysophosphatidylethanolamine acyltransferase 2;
DE            EC=2.3.1.n7;
DE   AltName: Full=Plasmalogen synthase;
GN   Name=LPCAT4; Synonyms=AGPAT7, AYTL3, LPEAT2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Testis;
RX   PubMed=16243729; DOI=10.1080/10425170500213712;
RA   Ye G.-M., Chen C., Huang S., Han D.-D., Guo J.-H., Wan B., Yu L.;
RT   "Cloning and characterization a novel human 1-acyl-sn-glycerol-3-
RT   phosphate acyltransferase gene AGPAT7.";
RL   DNA Seq. 16:386-390(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Ovary;
RA   Guo J.H., Yu L.;
RL   Submitted (JUL-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 268-414.
RC   TISSUE=Brain;
RA   Yu W., Sarginson J., Gibbs R.A.;
RL   Submitted (JUN-1998) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBSTRATE SPECIFICITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=18458083; DOI=10.1074/jbc.M800364200;
RA   Cao J., Shan D., Revett T., Li D., Wu L., Liu W., Tobin J.F.,
RA   Gimeno R.E.;
RT   "Molecular identification of a novel mammalian brain isoform of acyl-
RT   CoA:lysophospholipid acyltransferase with prominent ethanolamine
RT   lysophospholipid acylating activity, LPEAT2.";
RL   J. Biol. Chem. 283:19049-19057(2008).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Displays acyl-CoA-dependent lysophospholipid
CC       acyltransferase activity with a subset of lysophospholipids as
CC       substrates; converts lysophosphatidylethanolamine to
CC       phosphatidylethanolamine, lysophosphatidylcholine to
CC       phosphatidycholine, 1-alkenyl-lysophatidylethanolamine to 1-
CC       alkenyl-phosphatidylethanolamine, lysophosphatidylglycerol and
CC       alkyl-lysophosphatidylcholine to phosphatidylglycerol and alkyl-
CC       phosphatidylcholine, respectively. In contrast, has no
CC       lysophosphatidylinositol, glycerol-3-phosphate, diacylglycerol or
CC       lysophosphatidic acid acyltransferase activity. Prefers long chain
CC       acyl-CoAs (C16, C18) as acyl donors.
CC       {ECO:0000269|PubMed:18458083}.
CC   -!- CATALYTIC ACTIVITY: Acyl-CoA + 1-acyl-sn-glycero-3-
CC       phosphoethanolamine = CoA + 1,2-diacyl-sn-glycero-3-
CC       phosphoethanolamine. {ECO:0000269|PubMed:18458083}.
CC   -!- CATALYTIC ACTIVITY: Acyl-CoA + 1-alkenylglycerophosphoethanolamine
CC       = CoA + 1-alkenyl-2-acylglycerophosphoethanolamine.
CC       {ECO:0000269|PubMed:18458083}.
CC   -!- CATALYTIC ACTIVITY: Acyl-CoA + 1-acyl-sn-glycero-3-phosphocholine
CC       = CoA + 1,2-diacyl-sn-glycero-3-phosphocholine.
CC       {ECO:0000269|PubMed:18458083}.
CC   -!- CATALYTIC ACTIVITY: Acetyl-CoA + 1-alkyl-sn-glycero-3-
CC       phosphocholine = CoA + 2-acetyl-1-alkyl-sn-glycero-3-
CC       phosphocholine. {ECO:0000269|PubMed:18458083}.
CC   -!- CATALYTIC ACTIVITY: Acyl-CoA + 1-acyl-sn-glycero-3-
CC       phosphatidylserine = CoA + 1,2-diacyl-sn-glycero-3-
CC       phosphatidylserine. {ECO:0000269|PubMed:18458083}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=80 uM for lysophosphatidylethanolamine
CC         {ECO:0000269|PubMed:18458083};
CC         KM=20 uM for oleoyl-CoA {ECO:0000269|PubMed:18458083};
CC         Vmax=270 pmol/min/mg enzyme with lysophosphatidylethanolamine
CC         and oleoyl-CoA as substrates {ECO:0000269|PubMed:18458083};
CC   -!- PATHWAY: Lipid metabolism; phospholipid metabolism.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:16243729, ECO:0000269|PubMed:18458083}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:16243729,
CC       ECO:0000269|PubMed:18458083}.
CC   -!- TISSUE SPECIFICITY: Widely expressed with predominant level in
CC       brain. {ECO:0000269|PubMed:16243729, ECO:0000269|PubMed:18458083}.
CC   -!- SIMILARITY: Belongs to the 1-acyl-sn-glycerol-3-phosphate
CC       acyltransferase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC19156.1; Type=Frameshift; Positions=328; Evidence={ECO:0000305};
CC       Sequence=AAC19156.1; Type=Miscellaneous discrepancy; Note=Probable cloning artifact.; Evidence={ECO:0000305};
CC       Sequence=AAN33178.1; Type=Frameshift; Positions=198; Evidence={ECO:0000305};
CC       Sequence=AAP97722.1; Type=Frameshift; Positions=188, 198; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY734233; AAU34184.1; -; mRNA.
DR   EMBL; AF529233; AAP97722.1; ALT_FRAME; mRNA.
DR   EMBL; AF542964; AAN33178.1; ALT_FRAME; mRNA.
DR   EMBL; AK290273; BAF82962.1; -; mRNA.
DR   EMBL; CH471125; EAW92306.1; -; Genomic_DNA.
DR   EMBL; BC024892; AAH24892.2; -; mRNA.
DR   EMBL; BC092463; AAH92463.1; -; mRNA.
DR   EMBL; AF007155; AAC19156.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS32191.1; -.
DR   RefSeq; NP_705841.2; NM_153613.2.
DR   UniGene; Hs.352614; -.
DR   ProteinModelPortal; Q643R3; -.
DR   SMR; Q643R3; -.
DR   BioGrid; 129039; 10.
DR   STRING; 9606.ENSP00000317300; -.
DR   SwissLipids; SLP:000000294; -.
DR   iPTMnet; Q643R3; -.
DR   PhosphoSitePlus; Q643R3; -.
DR   SwissPalm; Q643R3; -.
DR   BioMuta; LPCAT4; -.
DR   DMDM; 74736281; -.
DR   EPD; Q643R3; -.
DR   MaxQB; Q643R3; -.
DR   PaxDb; Q643R3; -.
DR   PeptideAtlas; Q643R3; -.
DR   PRIDE; Q643R3; -.
DR   Ensembl; ENST00000314891; ENSP00000317300; ENSG00000176454.
DR   GeneID; 254531; -.
DR   KEGG; hsa:254531; -.
DR   UCSC; uc001zig.4; human.
DR   CTD; 254531; -.
DR   DisGeNET; 254531; -.
DR   GeneCards; LPCAT4; -.
DR   HGNC; HGNC:30059; LPCAT4.
DR   HPA; HPA030719; -.
DR   MIM; 612039; gene.
DR   neXtProt; NX_Q643R3; -.
DR   OpenTargets; ENSG00000176454; -.
DR   PharmGKB; PA162394297; -.
DR   eggNOG; KOG4666; Eukaryota.
DR   eggNOG; ENOG410XSIQ; LUCA.
DR   GeneTree; ENSGT00390000004914; -.
DR   HOGENOM; HOG000234374; -.
DR   InParanoid; Q643R3; -.
DR   KO; K13512; -.
DR   OMA; LRPPHTS; -.
DR   OrthoDB; EOG091G09LH; -.
DR   PhylomeDB; Q643R3; -.
DR   TreeFam; TF323244; -.
DR   BioCyc; MetaCyc:HS16664-MONOMER; -.
DR   BRENDA; 2.3.1.23; 2681.
DR   BRENDA; 2.3.1.51; 2681.
DR   Reactome; R-HSA-1482788; Acyl chain remodelling of PC.
DR   Reactome; R-HSA-1482801; Acyl chain remodelling of PS.
DR   Reactome; R-HSA-1482839; Acyl chain remodelling of PE.
DR   Reactome; R-HSA-1482925; Acyl chain remodelling of PG.
DR   Reactome; R-HSA-1483166; Synthesis of PA.
DR   Reactome; R-HSA-75109; Triglyceride Biosynthesis.
DR   UniPathway; UPA00085; -.
DR   GenomeRNAi; 254531; -.
DR   PRO; PR:Q643R3; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000176454; -.
DR   CleanEx; HS_LPCAT4; -.
DR   ExpressionAtlas; Q643R3; baseline and differential.
DR   Genevisible; Q643R3; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:MGI.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0003841; F:1-acylglycerol-3-phosphate O-acyltransferase activity; TAS:Reactome.
DR   GO; GO:0047184; F:1-acylglycerophosphocholine O-acyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0047166; F:1-alkenylglycerophosphoethanolamine O-acyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0047192; F:1-alkylglycerophosphocholine O-acetyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0047144; F:2-acylglycerol-3-phosphate O-acyltransferase activity; TAS:Reactome.
DR   GO; GO:0071617; F:lysophospholipid acyltransferase activity; IDA:MGI.
DR   GO; GO:0006654; P:phosphatidic acid biosynthetic process; TAS:Reactome.
DR   GO; GO:0036151; P:phosphatidylcholine acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0036152; P:phosphatidylethanolamine acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0036148; P:phosphatidylglycerol acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0036150; P:phosphatidylserine acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0006644; P:phospholipid metabolic process; IDA:MGI.
DR   GO; GO:0019432; P:triglyceride biosynthetic process; TAS:Reactome.
DR   InterPro; IPR002123; Plipid/glycerol_acylTrfase.
DR   Pfam; PF01553; Acyltransferase; 1.
DR   SMART; SM00563; PlsC; 1.
PE   1: Evidence at protein level;
KW   Acyltransferase; Complete proteome; Endoplasmic reticulum;
KW   Glycoprotein; Lipid biosynthesis; Lipid metabolism; Membrane;
KW   Phospholipid biosynthesis; Phospholipid metabolism;
KW   Reference proteome; Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN         1    524       Lysophospholipid acyltransferase LPCAT4.
FT                                /FTId=PRO_0000247054.
FT   TRANSMEM     40     62       Helical. {ECO:0000255}.
FT   TRANSMEM     87    107       Helical. {ECO:0000255}.
FT   MOTIF       129    134       HXXXXD motif.
FT   CARBOHYD    152    152       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   524 AA;  57219 MW;  3A2A12656E1241BC CRC64;
     MSQGSPGDWA PLDPTPGPPA SPNPFVHELH LSRLQRVKFC LLGALLAPIR VLLAFIVLFL
     LWPFAWLQVA GLSEEQLQEP ITGWRKTVCH NGVLGLSRLL FFLLGFLRIR VRGQRASRLQ
     APVLVAAPHS TFFDPIVLLP CDLPKVVSRA ENLSVPVIGA LLRFNQAILV SRHDPASRRR
     VVEEVRRRAT SGGKWPQVLF FPEGTCSNKK ALLKFKPGAF IAGVPVQPVL IRYPNSLDTT
     SWAWRGPGVL KVLWLTASQP CSIVDVEFLP VYHPSPEESR DPTLYANNVQ RVMAQALGIP
     ATECEFVGSL PVIVVGRLKV ALEPQLWELG KVLRKAGLSA GYVDAGAEPG RSRMISQEEF
     ARQLQLSDPQ TVAGAFGYFQ QDTKGLVDFR DVALALAALD GGRSLEELTR LAFELFAEEQ
     AEGPNRLLYK DGFSTILHLL LGSPHPAATA LHAELCQAGS SQGLSLCQFQ NFSLHDPLYG
     KLFSTYLRPP HTSRGTSQTP NASSPGNPTA LANGTVQAPK QKGD
//
